Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases만성 폐질환 환자에서 BNT162b2 COVID-19 백신 2회 접종 후 손상된 면역학적 결과와 관련된 항체 반응 및 위험 인자Article Published on 2022-07-012022-09-12 Journal: BMJ Open Respiratory Research [Category] MERS, 진단, [키워드] 1:1 1.26 95% CI adjusted antibody concentration Antibody Response aRR association Asthma bronchiectasis Charlson Comorbidity Index chronic pulmonary disease cohort study Comorbidity Control controls copd epidemiology COVID-19 COVID-19 vaccination COVID-19 vaccine defined dose Factor fibrosis first vaccination functional geometric healthcare personnel Humoral response identify immunological immunological responses Immunosuppression immunosuppressive Inclusion increasing age Interaction interstitial Interstitial Fibrosis lowest mRNA neutralising neutralising antibody of BNT162b2 outcome Patient Poisson regression Prednisolone Primary outcome Prospective quartile Receptor binding domain reported Responder response responses risk risk factor secondary outcome tested vaccination [DOI] 10.1136/bmjresp-2022-001268 PMC 바로가기 [Article Type] Article
Association of BNT162b2 Vaccine Third Dose Receipt With Incidence of SARS-CoV-2 Infection, COVID-19-Related Hospitalization, and Death Among Residents of Long-term Care Facilities, August to October 20212021년 8월부터 10월까지 장기요양시설 입소자 중 SARS-CoV-2 감염, COVID-19 관련 입원 및 사망 발생이 있는 BNT162b2 백신 3차 접종 협회Observational Study Published on 2022-07-012022-09-11 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 변종, 임상, [키워드] 95% CI 95% CIs adjusted age Analysis association BNT162b2 BNT162b2 vaccine booster dose Care caused Chain Reaction choice cohort study conducted COVID-19 COVID-19 vaccine COVID-19-related death cumulative cumulative incidence cumulative rate delta variant dose effective female follow-up duration follow-up period group hazard hazard ratios Hospitalization hospitalizations HRs immunogenic incidence IQR Kaplan-Meier curves less Long-term care median Mild-to-moderate Mortality multivariable Cox regression Observational cohort study occurred of BNT162b2 Older outcome participant polymerase chain reaction receipt recipient resident reverse transcription Reverse transcription-polymerase chain reaction RT-PCR SARS-CoV-2 SARS-COV-2 infection severe disease Surveillance the mean vaccination Vaccine vaccinee [DOI] 10.1001/jamanetworkopen.2022.19940 PMC 바로가기 [Article Type] Observational Study
Maternal COVID-19 and neonatal hearing loss: a multicentric survey산모 COVID-19 및 신생아 청력 상실: 다기관 조사Article Published on 2022-07-012022-09-11 Journal: European archives of oto-rhino-laryngology : offic [Category] COVID19(2023년), SARS, 치료기술, [키워드] cohort study Community Comorbidities Comorbidity COVID-19 COVID-19 infection detect determine Effect females first trimester Follow-up Health Hearing hearing loss incidence increased risk Infection male mandatory Maternal mother National Neonatal neonatal screening Neonatal screening. Neonate Neonates positive reported response retrospective cohort study SARS-COV-2 infection screening program sensorineural hearing loss severity virus was recorded were excluded [DOI] 10.1007/s00405-021-07098-5 PMC 바로가기 [Article Type] Article
Evaluation of the Correlation Between Responders and Non-Responders to the Second Coronavirus Disease Vaccination In Kidney Transplant Recipients: A Retrospective Single-Center Cohort StudyArticle Published on 2022-07-012022-11-15 Journal: Transplantation proceedings [Category] COVID19(2023년), SARS, 진단, [키워드] anti-SARS-CoV-2 IgG Antibody Response Antibody titer cofactor cohort study COVID-19 vaccination COVID-19 vaccine dosage dose evaluated Follow-up group groups healthy controls IgG level immune response Immunoglobulin kidney transplant kinetics of antibody median time Messenger RNA no significant difference Pfizer-BioNTech receiving recipient recipients retrospective SARS-CoV-2 second second dose second vaccination Serologic response significantly lower single-center the SARS-CoV-2 to define Transplant treated Vaccine [DOI] 10.1016/j.transproceed.2022.05.002 PMC 바로가기
Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults노인에서 세 번째 및 네 번째 SARS-CoV-2 BNT162b2 백신 투여 후 항체 역가Article Published on 2022-07-012022-09-12 Journal: JAMA Network Open [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Antibody titer cohort study dose evaluate Immunoglobulin individual Older SARS-CoV-2 BNT162b2 titer vaccine dose [DOI] 10.1001/jamanetworkopen.2022.23090 PMC 바로가기 [Article Type] Article
Hospitalization Outcomes Among Patients With COVID-19 Undergoing Remote MonitoringObservational Study Published on 2022-07-012022-10-04 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 임상, [키워드] 95% CI activated Activation adjusted age ambulatory patient Analysis association Care cohort study college Comorbidities COVID-19 demographics eligible groups Health care health system hospital Hospitalization Hospitalized inactivated intensive care inverse less likelihood median monitoring network Odds ratio outcome participant Patient patients with COVID-19 performed physician positive Positive test primary care regression analysis remote resource retrospective RPM SARS-CoV-2 test the mean was performed was used Weighting women [DOI] 10.1001/jamanetworkopen.2022.21050 PMC 바로가기 [Article Type] Observational Study
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design스코틀랜드의 증후성 질환에 대한 백신 부스터의 우려 및 효과에 대한 오미크론 변이의 심각도(EAVE II): 중첩 테스트 음성 디자인을 사용한 국가 코호트 연구Article Published on 2022-07-012022-09-11 Journal: The Lancet. Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI adjusted Admission booster booster dose Booster vaccine booster vaccines Care case-control study cohort analysis cohort study core COVID-19 defined Delta VOC dose dose of vaccination Edinburgh effective Effectiveness enhanced estimate Health Data Research UK Hospital admission hospitalisation individual individuals Infection initial Innovation laboratory data National offer omicron Omicron variant outcome platform positive positive RT-PCR proportion Public reduction in Reinfection risk risk of COVID-19 S-gene SARS-COV-2 infection Scottish severity Spread symptomatic symptomatic COVID-19 symptomatic disease symptomatic infection symptomatic SARS-CoV-2 infection tested the SARS-CoV-2 university vaccination Vaccine vaccine dose VoC with infection [DOI] 10.1016/S1473-3099(22)00141-4 PMC 바로가기 [Article Type] Article
Functional outcomes of COVID-19 patients with acute ischemic stroke: A prospective, observational, single-center study in North JordanObservational Study Published on 2022-07-012022-10-05 Journal: Medicine [Category] COVID19(2023년), SARS, 임상, [키워드] 95% confidence interval acute respiratory syndrome Admission age baseline cohort study conducted coronavirus coronavirus disease COVID-19 COVID-19 patient demographic data diagnosed discharge Follow-up functional had no in-hospital mortality increase in Infection involved Jordan Laboratory likelihood male median Mortality North Odds ratio outcome outcomes Patient patients predicted primary endpoint recorded recruited Risk factors SARS-CoV-2 SARS-COV-2 infection scale score secondary severity significantly single-center single-center study Standard deviation stroke Treatment variable Vascular [DOI] 10.1097/MD.0000000000029834 PMC 바로가기 [Article Type] Observational Study
Post-COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 InfectionSARS-CoV-2 감염 90일 후 어린이의 코로나19 이후 상태Article Published on 2022-07-012022-09-11 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 치료기술, [키워드] 48 hour 48 hours 95% CI acute illness addition adjusted odds ratio age children cohort study condition conditions conducted controls country Day defined enrolled Factor fatigue Follow-up Frequency Health Hospitalization Hospitalized index IQR median age nucleic acid nucleic acid testing Older outcome positive positive test result problem proportion prospective cohort study recruitment reported risk risk factor Risk factors SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 positivity Symptom test result tested the median weakness [DOI] 10.1001/jamanetworkopen.2022.23253 PMC 바로가기 [Article Type] Article
A historical cohort study to investigation of statins safety in COVID-19 hospitalized patientsResearch article Published on 2022-07-012022-10-05 Journal: Thérapie [Category] COVID19(2023년), SARS, 신약개발, [키워드] 95% CI addition Admission age anti-inflammatory properties association cardiovascular diseases Chronic kidney disease CKD cohort study condition conditions Corticosteroids COVID COVID-19 COVID-19 infected patients COVID-19 patient COVID19 decrease diabetes evaluated groups hospital Hospitalization hospitalized COVID-19 patients hospitalized patient hypertension ICU ICU admission implementation Inflammatory marker inhibitor intensive care Mortality mortality rate notable Odds ratio outcome proportion Result SARS-CoV-2 severity Sex shown significant difference significantly single-center statin statins statistical analysis Statistics stroke Tehran variable was performed [DOI] 10.1016/j.therap.2021.10.006 [Article Type] Research article